Certain tetrahydronaphthalenes used in the treatment of cardiac arrhythmia
    4.
    发明授权
    Certain tetrahydronaphthalenes used in the treatment of cardiac arrhythmia 失效
    某些四氢萘用于治疗心律失常

    公开(公告)号:US3930022A

    公开(公告)日:1975-12-30

    申请号:US48108974

    申请日:1974-06-20

    申请人: SQUIBB & SONS INC

    IPC分类号: C07D331/02 A61K31/135

    CPC分类号: C07D331/02 C07C2602/08

    摘要: AND THE PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, ARE USEFUL AS BETA-ADRENERGIC RECEPTOR BLOCKING AGENTS IN THE TREATMENT OF CARDIAC ARRHYTHMIA. In the above formula R1 can be alkyl or arylalkyl and R2 and R3 can each be hydrogen, hydroxyl, alkoxy, or arylalkoxy. Those compounds wherein R1 is arylalkyl and at least one of R2 and R3 is other than hydrogen are novel, and constitute a part of this invention.

    Tetrahydronaphthalenes having the structure

    摘要翻译: 具有结构和其药学上可接受的盐的四氢萘在治疗心脏病的过程中作为亚硝酸受体阻断剂有用。 在上式中,R 1可以是烷基或芳基烷基,R 2和R 3各自可以是氢,羟基,烷氧基或芳基烷氧基。 其中R 1为芳基烷基且R 2和R 3中的至少一个为氢的那些化合物是新颖的,构成本发明的一部分。